First Time Loading...
I

Immuneering Corp
NASDAQ:IMRX

Watchlist Manager
Immuneering Corp
NASDAQ:IMRX
Watchlist
Price: 1.37 USD -2.84% Market Closed
Updated: Jun 10, 2024

Immuneering Corp
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Immuneering Corp
Total Current Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
I
Immuneering Corp
NASDAQ:IMRX
Total Current Assets
$89.1m
CAGR 3-Years
33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Current Assets
$38.9B
CAGR 3-Years
14%
CAGR 5-Years
22%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Assets
$14B
CAGR 3-Years
2%
CAGR 5-Years
-16%
CAGR 10-Years
1%
Amgen Inc
NASDAQ:AMGN
Total Current Assets
$28B
CAGR 3-Years
10%
CAGR 5-Years
-4%
CAGR 10-Years
0%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Assets
$13.3B
CAGR 3-Years
16%
CAGR 5-Years
26%
CAGR 10-Years
25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Assets
$18.9B
CAGR 3-Years
23%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is Immuneering Corp's Total Current Assets?
Total Current Assets
89.1m USD

Based on the financial report for Dec 31, 2023, Immuneering Corp's Total Current Assets amounts to 89.1m USD.

What is Immuneering Corp's Total Current Assets growth rate?
Total Current Assets CAGR 3Y
33%

Over the last year, the Total Current Assets growth was -18%. The average annual Total Current Assets growth rates for Immuneering Corp have been 33% over the past three years .